Stocktoria
ABEONA THERAPEUTICS INC. ABEO
Nasdaq · XNAS · stock · Pharmaceutical Preparations · website · IPO 1980-09-19
ABEONA THERAPEUTICS INC. statistics & valuation
Market cap as of 2026-06-29. Multiples are price-derived and refreshed daily; everything else is from filings.
Key ratios (by fiscal year)
| Ratio | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Operating margin | -1536.9% | — | -1346.7% | -3600.8% | -2994.5% |
| Net margin | 1223.1% | — | -1548.2% | -2807.4% | -2831.2% |
| FCF margin | -1448.5% | — | -1066.9% | -3084.4% | -2327.2% |
| Return on assets | 32.4% | -58.5% | -84.7% | -61.8% | -106.7% |
| Return on equity | 44.7% | -144.7% | -365.5% | -148.3% | -200.5% |
| Debt / equity | 0.13× | 0.43× | — | — | — |
| Current ratio | 6.93 | 6.08 | 4.15 | 6.83 | 3.39 |
| Revenue growth | — | — | 147.5% | -52.9% | -70.0% |
Source: SEC EDGAR filings · CIK 0000318306 · as of 2025-12-31. Facts from filings plus Stocktoria's own computed scores — not investment advice.